ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

Recs

0
Player Avatar pchop123 (76.57) Submitted: 6/22/2012 3:05:21 PM : Outperform Start Price: $11.78 ISIS Score: +7.01

ISIS is rebounding now and far from done !!

Featured Broker Partners


Advertisement